Stem cell therapy for ALS (amyotrophic lateral sclerosis). MSC treatments provide neuroprotection for motor neurons, reduce neuroinflammation, and release neurotrophic factors to slow disease progression.
Stem cell therapy for ALS (amyotrophic lateral sclerosis / motor neuron disease) at StemCell Longevita in Istanbul provides neuroprotective support for motor neurons, reduces neuroinflammation, and aims to slow disease progression. While not a cure, our MSC treatments help patients preserve function and maintain quality of life longer than standard care alone.
ALS involves progressive degeneration of motor neurons in the brain and spinal cord. MSCs provide neuroprotection through multiple mechanisms: releasing neurotrophic factors (GDNF, BDNF, VEGF, IGF-1) that support motor neuron survival, suppressing microglial activation and neuroinflammation that accelerate motor neuron death, promoting neural repair pathways, and improving spinal cord blood flow. The goal is to slow the rate of motor neuron loss and preserve existing function.
Patients with diagnosed ALS at any stage, though earlier intervention yields better results as more motor neurons remain to protect. Patients with progressive muscular atrophy, primary lateral sclerosis, and progressive bulbar palsy may also benefit. Our neurological team evaluates ALSFRS-R scores and rate of decline to guide treatment decisions.
After neurological evaluation including ALSFRS-R scoring and electrophysiological studies, treatment involves combined IV and intrathecal MSC delivery. The intrathecal route is critical for ALS to deliver cells directly to the spinal fluid bathing the affected motor neurons. Multiple treatment sessions at 3-6 month intervals are typically recommended.
Potential stabilization or slowed decline on ALSFRS-R scores, preserved respiratory function longer, maintained motor function in affected limbs, reduced fasciculations, and improved quality of life. Results are most meaningful when treatment begins early and is repeated regularly.
Istanbul's neurological team has specific expertise in motor neuron disease. Combined IV + intrathecal MSC delivery protocol at costs 60-80% lower than Western ALS clinical programs.
ALS stem cell therapy from €8,500, including neurological assessment, combined IV + intrathecal MSC protocol, hotel, transfers, and ongoing follow-up.
Related treatments: Dementia Stem Cell Therapy | Alzheimer's Disease Stem Cell Therapy | Multiple Sclerosis Stem Cell Therapy | Parkinson's Disease Stem Cell Therapy | Parkinson's Disease Advanced Stem Cell Treatment
Pillar: stem cell therapy for neurological conditions in Istanbul
Related treatments: stem cell therapy for dementia and Alzheimer's in Istanbul | Alzheimer's disease stem cell therapy in Istanbul | Parkinson's disease stem cell treatment in Turkey | autism stem cell therapy at StemCell Longevita Istanbul | cerebral palsy stem cell therapy in Istanbul | post-stroke recovery with MSC therapy in Istanbul | spinal cord injury MSC treatment in Istanbul | ALS motor neuron disease stem cell therapy in Turkey | stem cell treatment for chronic migraines in Turkey
Research & guides: stem cell therapy for cerebral palsy research | MSC treatment for autism spectrum disorder | stem cell therapy for stroke recovery in Turkey | MSC treatment for spinal cord injury rehabilitation